iMeds.se

Serunato

SE/H/0436/001-002


Package leaflet: Information for the user


Serunato 50 mg film-coated tablets

Serunato 100 mg film-coated tablets


Sertraline


Read all of this leaflet carefully before you start taking this medicinebecause it contains important information for you.

- Keep this leaflet. You may need to read it again.

- If you have any further questions, ask your doctor or pharmacist.

- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.


What is in this leaflet

1. What Serunatois and what it is used for

2. What you need to know before you take Serunato

3. How to take Serunato

4. Possible side effects

5. How to store Serunato

6. Contents of the pack and other information


1. What Serunatois and what it is used for


Serunatocontains the active substance sertraline. Sertraline is one of a group of medicines called Selective Serotonin Re-uptake Inhibitors (SSRIs); these medicines are used to treat depression and or anxiety disorders.


Serunatocan be used to treat:

- Depression and prevention of recurrence of depression (in adults).

- Social anxiety disorder (in adults).

- Post traumatic stress disorder (PTSD) (in adults).

- Panic disorder (in adults).

- Obsessive compulsive disorder (OCD) (in adults and children and adolescents aged 6-17 years old).


Depression is a clinical illness with symptoms like feeling sad, unable to sleep properly or to enjoy life as you used to.


OCD and Panic disorders are illnesses linked to anxiety with symptoms like being constantly troubled by persistent ideas (obsessions) that make you carry out repetitive rituals (compulsions). PTSD is a condition that can occur after a very emotionally traumatic experience, and has some symptoms that are similar to depression and anxiety. Social anxiety disorder (social phobia) is an illness linked to anxiety. It is characterised by feelings of intense anxiety or distress in social situations (for example: talking to strangers, speaking in front of groups of people, eating or drinking in front of others or worrying that you might behave in an embarrassing manner).


Your doctor has decided that this medicine is suitable for treating your illness.


You should ask your doctor if you are unsure why you have been given Serunato.


2. What you need to know before you take Serunato


Do not take Serunato


Warnings and precautions

Talk to your doctor or pharmacist before taking Serunato.

Medicines are not always suitable for everyone. Tell your doctor before you take Serunato, if you suffer from or have suffered in the past from any of the following conditions:

- If you have epilepsy (fit) or a history of seizures. If you have a fit (seizure), contact your doctor immediately.

- If you have suffered from manic depressive illness (bipolar disorder) or schizophrenia. If you have a manic episode, contact your doctor immediately.

- If you have or have previously had thoughts of harming or killing yourself (see below “Thoughts of suicide and worsening of your depression or anxiety disorder”).

- If you have Serotonin Syndrome. In rare cases this syndrome may occur when you are taking certain medicines at the same time as sertraline (for symptoms, see section 4. “Possible side effects”). Your doctor will have told you whether you have suffered from this in the past.

- If you have low sodium level in your blood, since this can occur as a result of treatment with Serunato. You should also tell your doctor if you are taking certain medicines for hypertension, since these medicines may also alter the sodium level in your blood.

- If you are elderly as you may be more at risk of having low sodium level in your blood (see above).

- If you have liver disease; your doctor may decide that you should have a lower dose of Serunato.

- If you have diabetes; your blood glucose levels may be altered due to Serunatoand your diabetes medicines may need to be adjusted.

- If you have suffered from bleeding disorders or have been taking medicines which thin the blood (e.g. acetylsalicylic acid or warfarin) or may increase the risk of bleeding.

- If you are a child or adolescent under 18 years old. Serunatoshould only be used to treat children and adolescents aged 6-17 years old, suffering from obsessive compulsive disorder (OCD). If you are being treated for this disorder, your doctor will want to monitor you closely (see below “Children and adolescents”).

- If you are having electro-convulsive therapy (ECT).

- If you have eye problems, such as certain kinds of glaucoma (increased pressure in the eye).

- If you have been told that you have an abnormality of your heart tracing after an electrocardiogram (ECG) known as prolonged QT interval.


Effect on Urine Drug Screens

If you are having a urine drug screen, taking Serunatomay cause positive results for benzodiazepines. False-positive test results may be expected for several days following discontinuation of Serunato. If this happens, a more specific test can be performed.


Restlessness/Akathisia

The use of sertraline has been linked to a distressing restlessness and need to move, often being unable to sit or stand still (akathisia). This is most likely to occur during the first few weeks of treatment. Increasing the dose may be harmful so if you develop such symptoms you should talk to your doctor.


Withdrawal reactions

Side effects relating to stopping treatment (withdrawal reactions) are common, particularly if the treatment is stopped suddenly (see section 3. “If you stop taking Serunato” and section 4. “Possible side effects”). The risk of withdrawal symptoms depends on the length of treatment, dosage, and the rate at which the dose is reduced. Generally, such symptoms are mild to moderate. However, they can be serious in some patients. They normally occur within the first few days after stopping treatment. In general, such symptoms disappear on their own and wear off within 2 weeks. In some patients they may last longer (2-3 months or more). When stopping treatment with sertraline it is recommended to reduce the dose gradually over a period of several weeks or months, and you should always discuss the best way of stopping treatment with your doctor.


Thoughts of suicide and worsening of your depression or anxiety disorder

If you are depressed and/or have anxiety disorders you can sometimes have thoughts of harming or killing yourself. These may be increased when first starting antidepressants, since these medicines all take time to work, usually about two weeks but sometimes longer.

You may be more likely to think like this:

- If you have previously had thoughts about killing or harming yourself.

- If you are a young adult. Information from clinical trials has shown an increased risk of suicidal behaviour in adults aged less than 25 years with psychiatric conditions who were treated with an antidepressant.

If you have thoughts of harming or killing yourself at any time, contact your doctor or go to a hospital straight away.

You may find it helpful to tell a relative or close friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behaviour.


Children and adolescents

Sertraline should not usually be used in children and adolescents less than 18 years old, except for patients with Obsessive Compulsive Disorder (OCD). Patients under 18 have an increased risk of undesirable effects, such as suicide attempt, thoughts of harming or killing themselves (suicidal thoughts) and hostility (mainly aggressiveness, oppositional behaviour and anger) when they are treated with this class of medicines. Nevertheless, it is possible that your doctor decides to prescribe Serunatoto a patient under 18 if it is in the patient's interest. If your doctor has prescribed Serunatoto you and you are less than 18 years old and you want to discuss this, please contact him/her. Furthermore, if any of the symptoms listed above appear or worsen while you are taking Serunato, you should inform your doctor. Also, the long-term safety of Serunatoin regard to growth, maturation and learning (cognitive) and behavioural development in this age group has not yet been demonstrated.


Other medicines and Serunato

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.


Some medicines can affect the way Serunatoworks, or Serunatoitself can reduce the effectiveness of other medicines taken at the same time.


Taking Serunatotogether with the following medicines may cause serious side effects:

- Medicines called monoamine oxidase inhibitors (MAOIs), like moclobemide (to treat depression) and selegiline (to treat Parkinson’s disease), the antibiotic linezolid and methylene blue (to treat high levels of methaemoglobin in the blood). Do not use Serunatotogether with these medicines.

- Medicines to treat mental disorders such as psychosis (pimozide). Do not use Serunatotogether with pimozide.


Talk to your doctor if you are taking the following medicines:

- Herbal medicine containing St. John’s Wort (Hypericum perforatum). The effects of St. John’s Wort may last for 1-2 weeks.

- Products containing the amino acid tryptophan.

- Medicines to treat severe pain (e.g. tramadol).

- Medicines used in anaesthesia or to treat chronic pain (fentanyl, mivacurium and suxamethonium).

- Medicines to treat migraines (e.g. sumatriptan).

- Blood thinning medicine (warfarin).

- Medicines to treat pain/arthritis (Non steroidal anti-inflammatory drug (NSAID) such as ibuprofen, acetylsalicylic acid.

- Sedatives (diazepam).

- Diuretics (also called “water’ tablets”).

- Medicines to treat epilepsy (phenytoin, phenobarbital, carbamazepine).

- Medicines to treat diabetes (tolbutamide).

- Medicines to treat excessive stomach acid, ulcers and heartburn (cimetidine, omeprazole, lansoprazole, pantoprazole, rabeprazole).

- Medicines to treat mania and depression (lithium).

- Other medicines to treat depression (e.g. amitriptyline, nortriptyline, nefazodone, fluoxetine, fluvoxamine).

- Medicines to treat schizophrenia and other mental disorders (e.g. perphenazine, levomepromazine and olanzapine).

- Medicines used to treat high blood pressure, chest pain or regulate the rate and rhythm of the heart (e.g. verapamil, diltiazem, flecainide, propafenone).

- Medicines used to treat bacterial infections (e.g. rifampicin, clarithromycin, telithromycin, erythromycin).

- Medicines used to treat fungal infections (e.g. ketoconazole, itraconazole, posaconazole, voriconazole, fluconazole).

- Medicines used to treat HIV/AIDS and Hepatitis C (protease inhibitors such as ritonavir, telaprevir).

- Medicines used to prevent nausea and vomiting after an operation or chemotherapy (aprepitant).

- Medicines known to increase the risk of changes in the electrical activity of the heart (e.g. some antipsychotics and antibiotics).


Serunato with food, drink and alcohol

Serunatotablets can be taken with or without food.

Alcohol should be avoided whilst taking Serunato.

Serunatoshould not be taken in combination with grapefruit juice, as this may increase the level of sertraline in your body.


Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.


The safety of sertraline has not fully been established in pregnant women. Sertraline will only be given to you when pregnant if your doctor considers that the benefit for you is greater than any possible risk to the developing baby. If you are a woman capable of having children you should use a reliable method of contraception (such as the contraceptive pill), when taking sertraline.


Make sure your midwife and/or doctor know you are on Serunato. When taken during pregnancy, particularly in the last 3 months of pregnancy, medicines like Serunato may increase the risk of a serious condition in babies, called persistent pulmonary hypertension of the newborn (PPHN), making the baby breathe faster and appear bluish. These symptoms usually begin during the first 24 hours after the baby is born. If this happens to your baby you should contact your midwife and/or doctor immediately.


Your newborn baby might also have other conditions, which usually begin during the first 24 hours after birth. Symptoms include:

- trouble with breathing,

- a blueish skin or being too hot or cold,

- blue lips,

- vomiting or not feeding properly,

- being very tired, not able to sleep or crying a lot,

- stiff or floppy muscles,

- tremors, jitters or fits,

- increased reflex reactions,

- irritability,

- low blood sugar.

If your baby has any of these symptoms when it is born, or you are concerned about your baby’s health, contact your doctor or midwife who will be able to advise you.


There is evidence that sertraline passes into human breast milk. Sertraline should only be used in women during breast-feeding, if your doctor considers that the benefit exceeds any possible risk to the baby.


Some medicines like sertraline may reduce the quality of sperm in animal studies. Theoretically, this could affect fertility, but impact on human fertility has not been observed as yet.


Driving and using machines

Psychotropic drugs such as sertraline may influence your ability to drive or use machines. You should therefore not drive or operate machinery, until you know how this medication affects your ability to perform these activities.


Serunato contains lactose monohydrate

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.


3. How to take Serunato


Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.


The recommended dose is:

Adults

Depression and Obssessive Compulsive Disorder

For depression and OCD, the usual effective dose is 50 mg/day. The daily dose may be increased in 50 mg increments and at intervals of at least one week over a period of weeks. The maximum recommended dose is 200 mg/day.


Panic disorder, Social anxiety disorder and Post Traumatic Stress Disorder

For panic disorder, social anxiety disorder and post traumatic stress disorder, treatment should be started at 25 mg/day, and increased to 50 mg/day after one week.

The daily dose then may be increased in 50 mg increments over a period of weeks. The maximum recommended dose is 200 mg/day.


Use in children and adolescents

Serunatomust only be used to treat children and adolescents suffering from OCD aged 6-17 years old.

Obsessive Compulsive Disorder

Children aged 6 to 12: the recommended starting dose is 25 mg daily.

After one week, your doctor may increase this to 50 mg daily. The maximum dose is 200 mg daily.

Adolescents aged 13 to 17: the recommended starting dose is 50 mg daily.

The maximum dose is 200 mg daily.


If you have liver or kidney problems, please tell your doctor and follow the doctor’s instructions.


Method of administration

Serunatomay be taken with or without food.

Take your medication once daily either in the morning or evening.


Your doctor will advise you on how long to take this medication for. This will depend on the nature of your illness and how well you are responding to the treatment. It may take several weeks before your symptoms begin to improve. Treatment of depression should usually continue for 6 months after improvement.


If you take more Serunatothan you should

If you accidentally take too much Serunatocontact your doctor at once or go to the nearest hospital casualty department. Always take the labelled medicine package with you, whether there is any medication left or not.

Symptoms of overdose may include drowsiness, nausea and vomiting, rapid heart rate, shaking, agitation, dizziness and in rare cases unconsciousness.


If you forget to take Serunato

Do not take a double dose to make up for a forgotten dose. If you forget to take a dose, do not take the missed dose. Just take the next dose at the right time.


If you stop taking Serunato

Do not stop taking Serunatounless your doctor tells you to. Your doctor will want to gradually reduce your dose of Serunatoover several weeks, before you finally stop taking this medicine. If you suddenly stop taking this medicine you may experience side effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, feeling sick, being sick and shaking. If you experience any of these side effects, or any other side effects whilst stopping taking Serunato, please speak to your doctor.


If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


4. Possible side effects


Like all medicines, this medicine can cause side effects, although not everybody gets them.


Nausea is the most common side effect. The side effects depend on the dose and often disappear or lessen with continued treatment.


Tell your doctor immediately:

If you experience any of the following symptoms after taking this medicine, these symptoms can be serious.


The following side effects were seen in clinical trials in adults.


Very common (may affect more than 1 in 10 people)


Common (may affect up to 1 in 10 people)


Uncommon (may affect up to 1 in 100 people)


Rare (may affect up to 1 in 1,000 people)


After marketing sertraline, the following side effects have been reported


An increased risk of bone fractures has been observed in patients taking this type of medicines.


Additional side effects in children and adolescents

In clinical trials with children and adolescents, the side effects were generally similar to adults (see above). The most common side effects in children and adolescents were headache, insomnia, diarrhoea and feeling sick.


Symptoms that can occur when treatment is discontinued

If you suddenly stop taking this medicine you may experience side effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, feeling sick, being sick and shaking (see section 3. “If you stop taking Serunato”).


Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.


5. How to store Serunato


Keep this medicine out of the sight and reach of children.


Do not use this medicine after the expiry date which is stated on the carton after “EXP”. The expiry date refers to the last day of that month.


This medicinal product does not require any special storage conditions.


Do not throw away any medicines via wastewater <or household waste>. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


6. Contents of the pack and other information


What Serunatocontains


Serunato 50 mg film-coated tablets

The active substance is sertraline.

Each film-coated tablet contains 50 mg sertraline (as hydrochloride).

The other ingredients are

Tablet core:

Lactose monohydrate, microcrystalline cellulose, povidone K30, croscarmellose sodium, magnesium stearate.

Tablet coat:

Hypromellose 6, talc, propylene glycol, titanium dioxide (E 171).


Serunato 100 mg film-coated tablets

The active substance is sertraline.

Each film-coated tablet contains 100 mg sertraline (as hydrochloride).

The other ingredients are

Tablet core:

Lactose monohydrate, microcrystalline cellulose, povidone K30, croscarmellose sodium, magnesium stearate.

Tablet coat:

Hypromellose 6, hypromellose 15, talc, propylene glycol, titanium dioxide (E 171).


What Serunatolooks like and contents of the pack


Serunato 50 mg film-coated tablets

White, oval, biconvex film-coated tablets with score on one side and “L” on the other side


Serunato 100 mg film-coated tablets

White, round, biconvex film-coated tablets with score on one side and “C” on the other side.


Serunato 50 mg film-coated tablets

7, 14, 15, 20, 28, 30, 50, 60, 98, 100 250 and 500 film-coated tablets.

28x1, 30x1, 50x1, 98x1 and 100x1 film-coated tablets.


Serunato 100 mg film-coated tablets

7, 10, 14, 15, 20, 28, 30, 50, 60, 98, 100 250 and 500 film-coated tablets.

28x1, 30x1, 50x1, 98x1 and 100x1 film-coated tablets.


Not all pack sizes may be marketed.


Marketing Authorisation Holder and Manufacturer

<To be completed nationally>


This medicinal product is authorised in the Member States of the EEA under the following names:


Serunato 50 mg film-coated tablets

Sweden: Serunato

Germany: Sertralin-ratiopharm 50 mg Filmtabletten

Luxembourg: Sertralin-ratiopharm 50 mg Filmtabletten


Serunato 100 mg film-coated tablets

Sweden: Serunato

Germany: Sertralin-ratiopharm 100 mg Filmtabletten

Luxembourg: Sertralin-ratiopharm 100 mg Filmtabletten


This leaflet was last revised in 2016-04-20

17